Follow
Yu Shyr
Title
Cited by
Cited by
Year
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
BD Lehmann, JA Bauer, X Chen, ME Sanders, AB Chakravarthy, Y Shyr, ...
The Journal of clinical investigation 121 (7), 2750-2767, 2011
50612011
Survival in BRAF V600–mutant advanced melanoma treated with vemurafenib
JA Sosman, KB Kim, L Schuchter, R Gonzalez, AC Pavlick, JS Weber, ...
New England Journal of Medicine 366 (8), 707-714, 2012
23972012
Increase in Circulating Products of Lipid Peroxidation (F2-Isoprostanes) in Smokers — Smoking as a Cause of Oxidative Damage
JD Morrow, B Frei, AW Longmire, JM Gaziano, SM Lynch, Y Shyr, ...
New England Journal of Medicine 332 (18), 1198-1203, 1995
17411995
Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs
MG Kris, BE Johnson, LD Berry, DJ Kwiatkowski, AJ Iafrate, II Wistuba, ...
Jama 311 (19), 1998-2006, 2014
15582014
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
NM Kuderer, TK Choueiri, DP Shah, Y Shyr, SM Rubinstein, DR Rivera, ...
The Lancet 395 (10241), 1907-1918, 2020
15002020
Expansion of myeloid immune suppressor Gr+ CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis
L Yang, LM DeBusk, K Fukuda, B Fingleton, B Green-Jarvis, Y Shyr, ...
Cancer cell 6 (4), 409-421, 2004
12482004
Refinement of triple-negative breast cancer molecular subtypes: implications for neoadjuvant chemotherapy selection
BD Lehmann, B Jovanović, XI Chen, MV Estrada, KN Johnson, Y Shyr, ...
PloS one 11 (6), e0157368, 2016
10072016
Reproducibility of the diagnosis of dysplasia in Barrett esophagus: a reaffirmation
E Montgomery, MP Bronner, JR Goldblum, JK Greenson, MM Haber, ...
Human pathology 32 (4), 368-378, 2001
9862001
Proteomic patterns of tumour subsets in non-small-cell lung cancer
K Yanagisawa, Y Shyr, BJ Xu, PP Massion, PH Larsen, BC White, ...
The Lancet 362 (9382), 433-439, 2003
7882003
Regional cerebral activation in irritable bowel syndrome and control subjects with painful and nonpainful rectal distention
H Mertz, V Morgan, G Tanner, D Pickens, R Price, Y Shyr, R Kessler
Gastroenterology 118 (5), 842-848, 2000
7462000
The pan-ErbB negative regulator Lrig1 is an intestinal stem cell marker that functions as a tumor suppressor
AE Powell, Y Wang, Y Li, EJ Poulin, AL Means, MK Washington, ...
Cell 149 (1), 146-158, 2012
6862012
Experimentally derived metastasis gene expression profile predicts recurrence and death in patients with colon cancer
JJ Smith, NG Deane, F Wu, NB Merchant, B Zhang, A Jiang, P Lu, ...
Gastroenterology 138 (3), 958-968, 2010
6182010
Nationwide trends in mastectomy for early-stage breast cancer
KL Kummerow, L Du, DF Penson, Y Shyr, MA Hooks
JAMA surgery 150 (1), 9-16, 2015
6002015
Hyperactivation of phosphatidylinositol-3 kinase promotes escape from hormone dependence in estrogen receptor–positive human breast cancer
TW Miller, BT Hennessy, AM González-Angulo, EM Fox, GB Mills, H Chen, ...
The Journal of clinical investigation 120 (7), 2406-2413, 2010
5582010
Plasma cytokine levels predict mortality in patients with acute renal failure
EM Simmons, J Himmelfarb, MT Sezer, GM Chertow, RL Mehta, ...
Kidney international 65 (4), 1357-1365, 2004
5242004
Reamed intramedullary nailing of the femur: 551 cases
PR Wolinsky, E McCarty, Y Shyr, K Johnson
Journal of Trauma and Acute Care Surgery 46 (3), 392-399, 1999
4841999
Association of morbidity with markers of nutrition and inflammation in chronic hemodialysis patients: a prospective study
TA Ikizler, RL Wingard, J Harvell, Y Shyr, RM Hakim
Kidney international 55 (5), 1945-1951, 1999
4731999
Antioxidants enhance the cytotoxicity of chemotherapeutic agents in colorectal cancer: A p53-independent induction of p21WAF1/CIP1 via C/EBPβ
R Chinery, JA Brockman, MO Peeler, Y Shyr, RD Beauchamp, RJ Coffey
Nature medicine 3 (11), 1233-1241, 1997
4711997
DC isoketal-modified proteins activate T cells and promote hypertension
A Kirabo, V Fontana, APC De Faria, R Loperena, CL Galindo, J Wu, ...
The Journal of clinical investigation 124 (10), 4642-4656, 2014
4222014
Targeted Next Generation Sequencing Identifies Markers of Response to PD-1 BlockadeHybrid Capture–Based NGS and Response to Anti–PD-1
DB Johnson, GM Frampton, MJ Rioth, E Yusko, Y Xu, X Guo, RC Ennis, ...
Cancer immunology research 4 (11), 959-967, 2016
4142016
The system can't perform the operation now. Try again later.
Articles 1–20